Literature DB >> 18677713

Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes.

Kazuo Nakamura1, Sho-Ichi Yamagishi, Hisashi Adachi, Yayoi Kurita-Nakamura, Takanori Matsui, Hiroyoshi Inoue.   

Abstract

BACKGROUND: Pigment epithelium-derived factor (PEDF) inhibits endothelial cell injury. Further, serum levels of PEDF are elevated in the metabolic syndrome. These observations suggest that PEDF may be elevated as a counter-system against vascular cell damage in the metabolic syndrome. However, little is known about the regulation of PEDF in patients with diabetes. In order to clarify the determinants of serum PEDF, here, we examined the relationship between the 1-year changes in PEDF levels and those in anthropometric and metabolic variables in type 2 diabetic patients.
METHODS: Eighty-six consecutive outpatients with type 2 diabetes underwent a complete history and physical examination, determination of blood chemistries, and serum levels of PEDF at baseline and 1 year after. PEDF gene expression in cultured subcutaneous or omental adipocytes were analysed by quantitative real-time reverse transcription-polymerase chain reactions.
RESULTS: Multiple regression analyses revealed that waist circumference, triglycerides, creatinine, and TNF-alpha were independently associated with PEDF. Further, the percent changes in serum levels of PEDF during 1-year observational periods were positively correlated with those of BMI. In addition, PEDF mRNA levels in cultured adipocytes were increased in parallel to the BMI values of subjects from whom adipocytes were derived, especially in omental adipocytes.
CONCLUSION: These results demonstrated that serum levels of PEDF were positively associated with metabolic components and TNF-alpha in Japanese patients with type 2 diabetes. Our present study suggests that PEDF may be generated from adipose tissues and play some role in visceral obesity in type 2 diabetic patients. Copyright 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18677713     DOI: 10.1002/dmrr.820

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  24 in total

1.  Administration of pigment epithelium-derived factor inhibits left ventricular remodeling and improves cardiac function in rats with acute myocardial infarction.

Authors:  Shin-ichiro Ueda; Sho-ichi Yamagishi; Takanori Matsui; Yuko Jinnouchi; Tsutomu Imaizumi
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients.

Authors:  Alicia J Jenkins; Dongxu Fu; Madona Azar; Julie A Stoner; Derrick G Kaufman; Sarah Zhang; Richard L Klein; Maria F Lopes-Virella; Jian-Xing Ma; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2014-01-17       Impact factor: 2.852

3.  Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial.

Authors:  Catherine Duggan; Liren Xiao; Ching-Yun Wang; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-05       Impact factor: 4.254

4.  Association study of candidate gene polymorphisms and obesity in a young Mexican-American population from South Texas.

Authors:  Jorge Duran-Gonzalez; Ixiu Ortiz; Enrique Gonzales; Nicole Ruiz; Manti Ortiz; Arthur Gonzalez; Edna K Sanchez; Eugenia Curet; Susan Fisher-Hoch; Anne Rentfro; Huiqi Qu; Saraswathy Nair
Journal:  Arch Med Res       Date:  2011-11-01       Impact factor: 2.235

5.  Elevated plasma pigment epithelium-derived factor in children with type 2 diabetes mellitus is attributable to obesity.

Authors:  Jeanie B Tryggestad; Joshua J Wang; Sarah X Zhang; David M Thompson; Kevin R Short
Journal:  Pediatr Diabetes       Date:  2014-10-08       Impact factor: 4.866

6.  Identification of pigment epithelium-derived factor as an adipocyte-derived inflammatory factor.

Authors:  Sangeeta S Chavan; LaQueta K Hudson; Jian Hua Li; Mahendar Ochani; Yael Harris; Nirav B Patel; David Katz; Joshua A Scheinerman; Valentin A Pavlov; Kevin J Tracey
Journal:  Mol Med       Date:  2012-10-24       Impact factor: 6.354

7.  Molecular targets for diabetes mellitus-associated erectile dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; Moses T Tar; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2009-12-10       Impact factor: 5.911

8.  Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator.

Authors:  Chuhan Chung; Christine Shugrue; Anil Nagar; Jennifer A Doll; Mona Cornwell; Arijeet Gattu; Tom Kolodecik; Stephen J Pandol; Fred Gorelick
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

9.  Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells.

Authors:  Takumi Kawaguchi; Sho-Ichi Yamagishi; Minoru Itou; Koji Okuda; Shuji Sumie; Ryoko Kuromatsu; Masahiro Sakata; Mitsuhiko Abe; Eitaro Taniguchi; Hironori Koga; Masaru Harada; Takato Ueno; Michio Sata
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

10.  Emetine Di-HCl Attenuates Type 1 Diabetes Mellitus in Mice.

Authors:  LaQueta K Hudson; Meghan E Dancho; Jianhua Li; Johanna B Bruchfeld; Ahmed A Ragab; Mingzhu M He; Meaghan Bragg; Delaney Lenaghan; Michael D Quinn; Jason R Fritz; Matthew V Tanzi; Harold A Silverman; William M Hanes; Yaakov A Levine; Valentin A Pavlov; Peder S Olofsson; Jesse Roth; Yousef Al-Abed; Ulf Andersson; Kevin J Tracey; Sangeeta S Chavan
Journal:  Mol Med       Date:  2016-06-10       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.